Clinical Trial Update: Adults With Moderate to Severe Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial for adults with moderate to severe asthma sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED